Last verified: 1 day ago
CognatiQ
Also known as: Whole Coffee Fruit Extract, Coffee Cherry Extract, WCFE, NeuroFactor, Coffeeberry Extract
Evidence under review. — Not yet rated
Coffee fruit extract marketed to boost BDNF and improve memory and focus. Limited independent research.
-
What it does
CognatiQ is a proprietary whole coffee fruit (coffee cherry) extract standardized to 40% chlorogenic acid, made by FutureCeuticals. According to web-sourced industry and trade publications, it is...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
100-200 mg daily (per web sources; no PubMed data available)
What the Science Says
CognatiQ is a proprietary whole coffee fruit (coffee cherry) extract standardized to 40% chlorogenic acid, made by FutureCeuticals. According to web-sourced industry and trade publications, it is claimed to raise brain-derived neurotrophic factor (BDNF) levels, which plays a role in memory and learning. Manufacturer-cited studies suggest benefits to working memory and focus may appear within 7–28 days at 100 mg daily, but no independent PubMed-indexed clinical trials were available to verify these claims.
What It Doesn't Do
Not proven to prevent or treat any neurological disease. BDNF elevation in blood doesn't automatically mean better brain function. No independent large-scale trials confirm the memory and focus claims. Not a stimulant replacement — it contains little to no caffeine. Don't confuse marketing awards with peer-reviewed science.
Evidence-Based Benefits
May improve working memory and focus within 7–28 days at 100 mg daily.
Weak EvidenceEffective at: 100 mg daily
Linked to increased blood levels of BDNF, a protein involved in brain health.
Weak EvidenceEffective at: 100-200 mg daily
A single 200 mg dose may produce short-term improvements in cognitive performance.
Weak EvidenceEffective at: 200 mg (single dose)
Absorption & Bioavailability
Unknown — no pharmacokinetic data found in provided sources. Chlorogenic acids from coffee are generally moderately absorbed in humans, but specific data for this extract is unavailable.
Red Flags to Watch For
- All supporting studies appear to be funded by or conducted in partnership with the manufacturer (FutureCeuticals); no independent replication found in PubMed.
- Zero PubMed-indexed clinical trials found for 'CognatiQ' specifically — evidence base relies entirely on industry trade publications and manufacturer claims.
- BDNF blood level increases are used as a surrogate marker, but whether this translates to meaningful cognitive improvement in healthy adults is unproven.
- Appears in 26 registered supplement products (NIH DSLD), suggesting wide commercial use that outpaces the available independent evidence.
Frequently Asked Questions
What does CognatiQ do?
Coffee fruit extract marketed to boost BDNF and improve memory and focus. Limited independent research.
What is the effective dose of CognatiQ?
100-200 mg daily (per web sources; no PubMed data available)
Is CognatiQ safe?
All supporting studies appear to be funded by or conducted in partnership with the manufacturer (FutureCeuticals); no independent replication found in PubMed.
What doesn't CognatiQ do?
Not proven to prevent or treat any neurological disease.
Research Sources
- NIH DSLD
- Web
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-11-19